2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Published on Mar 17, 2019in Journal of the American College of Cardiology18.639
· DOI :10.1016/j.jacc.2019.03.009
Donna K. Arnett85
Estimated H-index: 85
Roger S. Blumenthal80
Estimated H-index: 80
+ 15 AuthorsBoback Ziaeian16
Estimated H-index: 16
Author(s): Arnett, Donna K; Blumenthal, Roger S; Albert, Michelle A; Buroker, Andrew B; Goldberger, Zachary D; Hahn, Ellen J; Himmelfarb, Cheryl D; Khera, Amit; Lloyd-Jones, Donald; McEvoy, J William; Michos, Erin D; Miedema, Michael D; Munoz, Daniel; Smith, Sidney C; Virani, Salim S; Williams, Kim A; Yeboah, Joseph; Ziaeian, Boback
Figures & Tables
  • References (416)
  • Citations (55)
📖 Papers frequently viewed together
1,640 Citations
112 Citations
148 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#2Marieke De Craemer (UGent: Ghent University)H-Index: 19
Last. Emmanuel Stamatakis (USYD: University of Sydney)H-Index: 64
view all 8 authors...
Aim To assess the relationship between time spent in light physical activity and cardiometabolic health and mortality in adults. Design Systematic review and meta-analysis. Data sources Searches in Medline, Embase, PsycInfo, CINAHL and three rounds of hand searches. Eligibility criteria for selecting studies Experimental (including acute mechanistic studies and physical activity intervention programme) and observational studies (excluding case and case–control studies) conducted in adults (aged ...
25 CitationsSource
Abstract Background The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. Methods We randomly assigned patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease to receive either dapagliflozin or placebo. The primary safety outcome was a composite of major adverse cardiovascular events (MACE), defined as cardiovascular death, myocar...
357 CitationsSource
#1Thomas A. Zelniker (Brigham and Women's Hospital)H-Index: 12
#2Stephen D. Wiviott (Brigham and Women's Hospital)H-Index: 67
Last. Marc S. Sabatine (Brigham and Women's Hospital)H-Index: 90
view all 15 authors...
Summary Background The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on specific cardiovascular and renal outcomes and whether heterogeneity is based on key baseline characteristics remains undefined. Methods We did a systematic review and meta-analysis of randomised, placebo-controlled, cardiovascular outcome trials of SGLT2i in patients with type 2 diabetes. We searched PubMed and Embase for trials published up to Sept 24, 2018. Data search and extraction were compl...
222 CitationsSource
James L. Januzzi Jr, MD, FACC, Chair Tariq Ahmad, MD, MPH, FACC Brendan Everett, MD, FACC William Hucker, MD, PhD Dharam J. Kumbhani, MD, SM, FACC Joseph E. Marine, MD, FACC Pamela B. Morris, MD, FACC Robert N. Piana, MD, FACC Sunil V. Rao, MD, FACC Marielle Scherrer-Crosbie, MD, PhD
20 CitationsSource
#1Mahshid Dehghan (Population Health Research Institute)H-Index: 24
#2Andrew Mente (McMaster University)H-Index: 32
Last. Salim Yusuf Mb Bs DPhil Frcpc (Independence University)H-Index: 214
view all 39 authors...
Summary Background Dietary guidelines recommend minimising consumption of whole-fat dairy products, as they are a source of saturated fats and presumed to adversely affect blood lipids and increase cardiovascular disease and mortality. Evidence for this contention is sparse and few data for the effects of dairy consumption on health are available from low-income and middle-income countries. Therefore, we aimed to assess the associations between total dairy and specific types of dairy products wi...
43 CitationsSource
#1Joshua D. Mitchell (WashU: Washington University in St. Louis)H-Index: 12
#2Nicole Fergestrom (MCW: Medical College of Wisconsin)H-Index: 1
Last. Todd C. Villines (Walter Reed National Military Medical Center)H-Index: 38
view all 9 authors...
Abstract Background Compared with traditional risk factors, coronary artery calcium (CAC) scores improve prognostic accuracy for atherosclerotic cardiovascular disease (ASCVD) outcomes. However, the relative impact of statins on ASCVD outcomes stratified by CAC scores is unknown. Objectives The authors sought to determine whether CAC can identify patients most likely to benefit from statin treatment. Methods The authors identified consecutive subjects without pre-existing ASCVD or malignancy who...
21 CitationsSource
#1Adrian F. Hernandez (Duke University)H-Index: 81
#2Jennifer B. Green (Duke University)H-Index: 18
Last. Trisha MandalH-Index: 1
view all 799 authors...
Summary Background Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patien...
165 CitationsSource
#1Paul K. Whelton (American College of Preventive Medicine)H-Index: 24
#2Robert M. Carey (American College of Preventive Medicine)H-Index: 2
Last. Jackson T. Wright (American College of Preventive Medicine)H-Index: 14
view all 21 authors...
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, MS, PharmD, AACC Biykem Bozkurt, MD, PhD, FACC, FAHA
1,268 CitationsSource
#2Louise BowmanH-Index: 18
#3Marion MafhamH-Index: 9
Last. Jane ArmitageH-Index: 50
view all 27 authors...
148 CitationsSource
Between 1853 and 1897, German chemists learned to efficiently combine sodium salicylate with acetyl chloride to produce acetylsalicylic acid. That compound, trademarked as aspirin, proved to be a r...
18 CitationsSource
Cited By55
#1Simon L. Bacon (Concordia University)H-Index: 35
#2Tavis S. Campbell (U of C: University of Calgary)H-Index: 31
Last. Kim L. Lavoie (UQAM: Université du Québec à Montréal)H-Index: 30
view all 3 authors...
In spite of the substantial amount of work that has been done to date, cardiovascular disease (CVD) is still the leading global cause of mortality and morbidity ([1][1]). In addition, to the human burden of CVD, there is a significant financial burden. For example, in the United States, it is
#1Leslie Cho (Cleveland Clinic)H-Index: 24
#2Melinda B. Davis (UM: University of Michigan)H-Index: 7
Last. Viola Vaccarino (Emory University)H-Index: 86
view all 11 authors...
Abstract Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee unde...
#1Nathan O. Stitziel (WashU: Washington University in St. Louis)H-Index: 23
#2Jenny E. Kanter (UW: University of Washington)H-Index: 13
Last. Karin E. Bornfeldt (UW: University of Washington)H-Index: 43
view all 3 authors...
Type 1 and type 2 diabetes mellitus (T1DM and T2DM) increase the risk of atherosclerotic cardiovascular disease (CVD), resulting in acute cardiovascular events, such as heart attack and stroke. Recent clinical trials point toward new treatment and prevention strategies for cardiovascular complications of T2DM. New antidiabetic agents show unexpected cardioprotective benefits. Moreover, genetic and reverse translational strategies have revealed potential novel targets for CVD prevention in diabet...
#1Ikenna C. Ohanenye (U of O: University of Ottawa)
#2Apollinaire Tsopmo (Carleton University)
Last. Chibuike C. Udenigwe (U of O: University of Ottawa)H-Index: 27
view all 4 authors...
Abstract Background Proteins are essential macronutrients of the human diet. Currently, major dietary sources in developed countries are of animal origin. However, the association of red meat consumption to the increased risks of some health conditions and its unsustainable pressure on the environment have increased the interest in plant proteins as healthier and sustainable alternatives. Of these, legumes have a great potential, but part of their proteins are indigestible due to interaction wit...
#1Adrian RosadaH-Index: 5
#2Ursula KassnerH-Index: 12
Last. Dominik SpiraH-Index: 8
view all 7 authors...
#1Clare ArnottH-Index: 5
Last. Mark WoodwardH-Index: 115
view all 9 authors...
Background and objective Hypertensive disorders of pregnancy (HDPs) affect 5%–10% of pregnancies and have been associated with excess maternal cardiovascular disease (CVD) risk. The primary aim of this study was to reliably estimate absolute and relative risks of CVD after HDP. Methods A retrospective cohort of women who had singleton pregnancies in New South Wales, Australia, between 2002 and 2016 and identified using linked population health administrative databases. The primary exposure was n...
#1Richard L. Weinberg (UM: University of Michigan)H-Index: 5
#2Melvyn Rubenfire (UM: University of Michigan)H-Index: 42
Last. Robert D. Brook (UM: University of Michigan)H-Index: 55
view all 3 authors...
Coronary artery calcium (CAC) is increased by high blood pressure (BP), predicts new-onset hypertension, and is a powerful predictor of atherosclerotic cardiovascular disease events in patients with and without hypertension. Unlike other diseases (e.g., hypercholesterolemia), the clinical use of CAC scoring to personalize the treatment of high BP has not received much attention and therefore remains less well defined. Herein, we provide an updated review of studies investigating the relationship...
#1Francesca Gorini (National Research Council)H-Index: 3
#2Elisa Bustaffa (National Research Council)H-Index: 5
Last. Francesco Squadrito (UNIME: University of Messina)H-Index: 59
view all 13 authors...
Introduction Environmental pollution has been progressively becoming one of the main risk factors to human diseases. In particular, populations living in high-contaminated sites are particularly exposed to environmental toxicants, with consequent increased risks to human health. In Italy, there are currently ongoing three epidemiological etiological studies aimed at evaluating the association between exposure to inorganic and organic chemicals and presence of biological markers of early effects ...